Literature DB >> 20684613

Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.

Peter Schmidtke1, Xavier Barril.   

Abstract

Druggability predictions are important to avoid intractable targets and to focus drug discovery efforts on sites offering better prospects. However, few druggability prediction tools have been released and none has been extensively tested. Here, a set of druggable and nondruggable cavities has been compiled in a collaborative platform ( http://fpocket.sourceforge.net/dcd ) that can be used, contributed, and curated by the community. Druggable binding sites are often oversimplified as closed, hydrophobic cavities, but data set analysis reveals that polar groups in druggable binding sites have properties that enable them to play a decisive role in ligand recognition. Finally, the data set has been used in conjunction with the open source fpocket suite to train and validate a logistic model. State of the art performance was achieved for predicting druggability on known binding sites and on virtual screening experiments where druggable pockets are retrieved from a pool of decoys. The algorithm is free, extremely fast, and can effectively be used to automatically sieve through massive collections of structures ( http://fpocket.sourceforge.net ).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684613     DOI: 10.1021/jm100574m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  82 in total

1.  Molecular simulation methods in drug discovery: a prospective outlook.

Authors:  Xavier Barril; F Javier Luque
Journal:  J Comput Aided Mol Des       Date:  2011-12-08       Impact factor: 3.686

2.  Quantifying the chemical beauty of drugs.

Authors:  G Richard Bickerton; Gaia V Paolini; Jérémy Besnard; Sorel Muresan; Andrew L Hopkins
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

3.  A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs).

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  PLoS Comput Biol       Date:  2018-11-08       Impact factor: 4.475

4.  Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV).

Authors:  Aurelio Bonavia; Michael Franti; Erin Pusateri Keaney; Kelli Kuhen; Mohindra Seepersaud; Branko Radetich; Jian Shao; Ayako Honda; Janetta Dewhurst; Kara Balabanis; James Monroe; Karen Wolff; Colin Osborne; Leanne Lanieri; Keith Hoffmaster; Jakal Amin; Judit Markovits; Michelle Broome; Elizabeth Skuba; Ivan Cornella-Taracido; Gerard Joberty; Tewis Bouwmeester; Lawrence Hamann; John A Tallarico; Ruben Tommasi; Teresa Compton; Simon M Bushell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

Review 5.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

Review 6.  Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

Authors:  Wim G J Hol
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-16       Impact factor: 1.056

7.  Binding site characterization - similarity, promiscuity, and druggability.

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  Medchemcomm       Date:  2019-06-06       Impact factor: 3.597

8.  Elucidating the druggability of the human proteome with eFindSite.

Authors:  Omar Kana; Michal Brylinski
Journal:  J Comput Aided Mol Des       Date:  2019-03-19       Impact factor: 3.686

Review 9.  Pocket-based drug design: exploring pocket space.

Authors:  Xiliang Zheng; Linfeng Gan; Erkang Wang; Jin Wang
Journal:  AAPS J       Date:  2012-11-22       Impact factor: 4.009

10.  Structural basis of bacterial defense against g-type lysozyme-based innate immunity.

Authors:  S Leysen; L Vanderkelen; S D Weeks; C W Michiels; S V Strelkov
Journal:  Cell Mol Life Sci       Date:  2012-10-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.